This acquisition will help generate data from over four million members of MyHealthTeams’ opted-in patient universe.
Swoop announced its acquisition of MyHealthTeam, creator of one of the largest opted-in patient social networks in the US. The companies share a vision of making vetted information more available for patients, as well as providing them with peers and a community for support.
“We acquired MyHealthTeam–a leading opted-in patient universe–because of their adept ability to build trusted, condition-specific patient communities at scale,” said Ron Elwell, founder and CEO of Swoop, in a press release. “This acquisition builds on our already strong position…by strategically 'bookending' privacy-compliant marketing, we will be able to provide even further value to pharma brands and patients…Together, we help pharma brands build deep and authentic relationships in the patient community, and reinforce that messaging with treating physicians, and in every channel across the web and TV.”1
MyHealthTeam leverages information from four million of patients spanning across chronic and rare diseases areas like Alzheimer’s, COPD, diabetes, various cancers, and more.2 The patient social networks not only have virtual communities to elicit insights from but also provide data, which is privacy compliant, that can help healthcare marketers understand patient needs from a new perspective. This has been a focus for Swoop since spinning off from Real Chemistry in early September 2024.3
The two companies hope that the combination of this data and insights into the more than 62 communities will inform more omnichannel marketing decisions—fostering stronger connections between patients, brands, and healthcare providers. This would help keep the balance of targeted marketing while maintaining patient privacy, a common challenge for pharmaceutical marketers.
Aside from the ability to share their experiences and ailments with other members of their community, MyHealthTeam members can also find support and information. “More than anything else, our members facing chronic and rare conditions want to know what’s coming around the next corner and how they can best prepare for it," said Eric Peacock, co-founder and CEO of MyHealthTeam. “They connect and chat with other members, they consume the medically-approved articles and videos we create for them, and now we can bring Swoop’s vast depth of claims data, machine learning and AI capabilities to bear in delivering them information that is personalized based on where they are in their patient journey.”1
Plans to launch additional communities in many more conditions this year are already in the works.
“Our mission at Swoop has always been to harness the power of data and AI to create impactful, privacy-first solutions that connect patients and healthcare providers,” Scott Rines, president of Swoop added, “By integrating MyHealthTeam’s vibrant social communities into our omnichannel marketing suite, we’re advancing [that mission] in a monumental way. Together, we are bridging the gap between healthcare brands and patients to create more impactful, targeted, and seamless engagement strategies to ultimately improve patients’ outcomes.”1
Financial details of this acquisition have not been disclosed.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.